![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
177 épisodes
![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
BackTable Urology BackTable
-
- Forme et santé
The BackTable Urology Podcast is a resource for practicing urologists to learn tips, techniques, and practical advice from their peers in the field. Listen here or on the streaming platform of your choice.
-
Ep. 174 HoLEP: Advanced Techniques and Patient Outcomes with Dr. Spencer Hiller
In this episode of the BackTable Urology Podcast, Dr. Jose Silva and Dr. Spencer Hiller discuss holmium laser enucleation of the prostate (HoLEP), including preoperative and postoperative care, and the technical nuances of the procedure.
---
CHECK OUT OUR SPONSOR
Siemens Healthineers Theranostics
https://www.siemens-healthineers.com/en-us/clinical-specialities/theranostics
---
SYNPOSIS
Dr. Hiller emphasizes the importance of patient education, bladder retraining, and the holistic management of incontinence. The conversation also touches on the science of lasers, effective morcellation, and practical challenges in achieving successful outcomes.
---
TIMESTAMPS
00:00 - Introduction
07:58 - HoLEP Patient Counseling
21:29 - HoLEP Surgical Techniques
33:54 - Morcellation: Challenges and Best Practices
37:16 - Post-Operative Care
47:21 - Postoperative Urinary Symptoms -
Ep. 173 AI Scribes: Enhancing Patient and Physician Interaction with Elie Toubiana
Dr. Aditya Bagrodia sits down with Elie Toubiana, founder and CEO of ScribeMD.ai, to discuss the transformative potential of artificial intelligence (AI) in medical documentation.
---
SYNPOSIS
Their conversation covers the capabilities and benefits of using an AI-driven medical scribe that ensures HIPAA compliance, reduces physician burnout, and enhances patient interactions. Elie also shares his insights about the technology’s adaptability across various medical fields. Finally, Dr. Bagrodia and Elie discuss ethical considerations surrounding applications of AI in other aspects of healthcare, such as medical workup and diagnosis.
---
TIMESTAMPS
00:00 - Introduction
06:00 - How ScribeMD AI Works
14:14 - Integration with EMR
20:31 - Legal Considerations with AI Technology
26:34 - Cost Implications of AI Scribes
38:46 - Future of AI in Medical Diagnosis
41:45 - Conclusion and Final Thoughts
---
RESOURCES
ScribeMD.ai
https://www.scribemd.ai/ -
Ep. 172 Advancing Cancer Care: AUA 2024 Highlights in Prostate and Bladder Cancer with Dr. Jeff Tosoian and Dr. Woodson Smelser
In this episode of the BackTable Urology, Dr. Bogdana Schmidt (University of Utah), Dr. Woodson Smelser (Washington University in St. Louis), and Dr. Jeff Tosoian (Vanderbilt University) discusses the latest insights and advancements in prostate and bladder cancer treatment presented at AUA 2024.
---
CHECK OUT OUR SPONSOR
Veracyte
https://www.veracyte.com/decipher
---
SYNPOSIS
First, the doctors cover noteworthy topics, including the effectiveness of early screening and treatment for high-risk prostate cancer patients, innovative approaches in imaging and biomarkers, and the impact of new guidelines on salvage therapy. They also explore emerging treatments for non-muscle invasive bladder cancer (NMIBC), as well as the evolving role of systemic immunotherapies and advanced genomic testing. To wrap up, the urologists offer detailed analyses and their expert opinions on how these developments could transform patient care in the field of urologic oncology.
---
TIMESTAMPS
00:00 - Introductions
03:06 - Prostate Cancer Screening Insights
10:10 - Advancements in MRI and Biomarkers
18:22 - Transperineal vs. Transrectal Prostate Biopsy
27:18 - New Guidelines for Bladder Cancer Treatment
30:57 - Innovative Drug Delivery Systems
32:36 - Gene Therapy and Immunotherapy Advances
40:11 - Concluding Thoughts and Future Prospects
---
RESOURCES
Decipher Prostate Genomic Classifier by Veracyte:
https://decipherbio.com/decipher-prostate/physicians/decipher-prostate-overview/ -
Ep. 171 Rethinking Healthcare Administration and Policy with Dr. Mara Holton and Dr. Josh Langston
In this episode of Back Table Urology, Dr. Aditya Bagrodia, Dr. Joshua Langston, and Dr. Mara Holton from the Large Urology Group Practice Association (LUGPA) share insights on the financial and administrative complexities that urologists face.
---
CHECK OUT OUR SPONSOR
Fellow
https://www.meetfellow.com/
---
SYNPOSIS
The doctors delve into the increasing costs of healthcare, the challenges posed by regulatory requirements, and the significance of physician leadership in influencing healthcare delivery. The discussion also highlights the importance of advocacy, the evolving role of physicians in business and policy, and actionable steps doctors can take to ensure their voices are heard. Finally, the doctors address the growing trend of hospital employment among physicians and its impact on rural healthcare access.
---
TIMESTAMPS
00:00 - Introduction
06:41 - Complexities and Costs in Healthcare
11:48 - The Role of Physicians in Healthcare Leadership
17:21 - The Shift Towards Hospital Employment
27:35 - Economic Pressures on Physicians and Patients
30:09 - Cost Discrepancies in Medical Procedures
38:16 - Burnout and Workforce Challenges
49:26 - Advocacy and Call to Action
---
RESOURCES
Fellow
https://www.meetfellow.com/
BackTable URO Ep. 82- Advocacy Basics for the Urologist: From Your Clinic to Capitol Hill with Dr. Ruchika Talwar
https://open.spotify.com/episode/0hcLrKuf5QU7TZCHSErs4Z?si=842c7985f44c4e04
BackTable URO Ep. 164: Urology Advocacy: From Passion to Policy with Dr. Seth Cohen, Dr. Michelle Leach, and Dr. Suzette Sutherland
https://open.spotify.com/episode/68pR7MxFIgQ1HJLy6xQHDX?si=36a93eedd6594770 -
Ep. 170 GSRGT: Collaborative Approaches to Rare GU Oncology with Dr. Philippe Spiess and Dr. Andrea Necchi
In this episode of BackTable Urology, host Dr. Aditya Bagrodia, urologic oncologist Dr. Philippe Speiss (Moffitt Cancer Center), and medical oncologist Dr. Andrea Necchi (Università Vita-Salute San Raffaele) have an in-depth discussion about the mission and achievements of the Global Society of Rare Genitourinary Tumors (GSRGT).
---
CHECK OUT OUR SPONSORS
Siemens Healthineers Theranostics
https://www.siemens-healthineers.com/en-us/clinical-specialities/theranostics
Veracyte
https://www.veracyte.com/decipher
---
SYNPOSIS
First, the doctors discuss the society’s mission to improve the diagnosis and treatment of rare genitourinary cancers globally. They give an overview of their educational efforts, international collaborations, and significant achievements in clinical research. The discussion also covers the importance of global representation, the challenges of studying rare tumors, and future directions, such as leveraging artificial intelligence. The episode concludes with an emphasis on the society’s commitment to being inclusive and providing opportunities for young investigators.
---
TIMESTAMPS
00:00 - Introduction
06:45 - Origins and Missions of GSRGT
11:21 - Challenges in Rare Cancer Research
31:51 - Future Directions in Rare Cancer Treatment
38:38 - How to Get Involved with GSRGT
---
RESOURCES
Siemens Healthineers Theranostics:
https://www.siemens-healthineers.com/en-us/clinical-specialities/theranostics
Decipher Prostate Genomic Classifier by Veracyte:
https://decipherbio.com/decipher-prostate/physicians/decipher-prostate-overview/
GSRGT Website
https://www.gsrgt.com/
Andrea Necchi Website
https://www.andreanecchi.com/ -
Ep. 169 Prostate Cancer: Navigating Focal Therapy Options with Dr. Matthew Cooperberg and Dr. Arvin George
In this episode, Dr. Matthew Cooperberg (UC San Francisco) and Dr. Arvin George (Johns Hopkins) join host Dr. Aditya Bagrodia in a conversation about guidelines and treatment algorithms for focal therapy in prostate cancer treatment.
---
CHECK OUT OUR SPONSORS
Siemens Healthineers Theranostics
https://www.siemens-healthineers.com/en-us/clinical-specialities/theranostics
Veracyte
https://www.veracyte.com/decipher
---
SYNPOSIS
First, the doctors discuss focal therapy in prostate cancer treatment from various perspectives, including the challenges of treating certain lesions, the comparison of different focal therapy modalities like high-intensity focused ultrasound (HIFU) and brachytherapy, cryotherapy and the importance of patient-specific factors in treatment decisions. They emphasize the need for clinical trials and registries to validate focal therapy outcomes, the potential expansion of indications for focal therapy, and the critical role of advanced imaging and genomic classifiers in patient selection and treatment planning. The discussion also touches on the potential of focal therapy to evolve as a standard care option alongside advancements in understanding the biology of prostate cancer and improving imaging and treatment technologies.
---
TIMESTAMPS
Siemens Healthineers Theranostics:
https://www.siemens-healthineers.com/en-us/clinical-specialities/theranostics
Decipher Prostate Genomic Classifier by Veracyte:
https://decipherbio.com/decipher-prostate/physicians/decipher-prostate-overview/
---
RESOURCES
Siemens Healthineers Theranostics:
https://www.siemens-healthineers.com/en-us/clinical-specialities/theranostics
Decipher Prostate Genomic Classifier by Veracyte:
https://decipherbio.com/decipher-prostate/physicians/decipher-prostate-overview/